Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more) Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News OncoSec Medical Inc ONCSQ

Healthcare Biotechnology
OncoSec Medical Incorporated is a late-stage immuno-oncology company. The Company is focused on designing, developing and commercializing intra-tumoral DNA-based therapeutics delivered by electroporation (EP) to stimulate and augment anti-tumor immune responses for the treatment of cancers. Its core technology, ImmunoPulse, is a drug-device therapeutic modality platform comprised of an OncoSec... see more

Recent & Breaking News (GREY:ONCSQ)

OncoSec Collaborates with Smart Patients to Form New Online Community for Patients

Business Wire April 18, 2013

OncoSec Medical to Present at the 2013 BIO International Convention on April 24

Business Wire April 17, 2013

OncoSec Medical Incorporated - Life Sciences and Innovation

Accesswire April 2, 2013

OncoSec Medical President and CEO, Punit Dhillon Publishes Blog Post Titled ''Building Relationships between Biotech Corporations and Academia''

Accesswire March 25, 2013

OncoSec Medical Incorporated President Punit Dhillon Publishes New Blog Post Titled - Why More Biotechs Should ''Go Social''

Accesswire March 18, 2013

OncoSec Medical to Present at the HemOnc Today Melanoma and Cutaneous Malignancies Meeting in New York

PR Newswire March 18, 2013

OncoSec Medical to Present at the 25th Annual Roth Conference

PR Newswire March 14, 2013

OncoSec Medical Announces Formation of Melanoma Advisory Board

PR Newswire February 26, 2013

OncoSec Medical Promotes Veronica Vallejo to Chief Financial Officer

PR Newswire February 19, 2013

OncoSec Medical to Present at the 15th Annual BIO CEO & Investor Conference

PR Newswire February 6, 2013

OncoSec Medical to Present at Noble Financial Capital Markets' Ninth Annual Equity Conference on January 22

PR Newswire January 17, 2013

OncoSec Medical Announces 2013 Milestones and Corporate Strategy

PR Newswire January 15, 2013

Noble Financial January 22-23 Equity Conference Attracts More Than 100 Public Companies

Marketwired January 11, 2013

OncoSec Medical to Present at Biotech Showcase(TM) 2013 in San Francisco on January 8

PR Newswire January 3, 2013